Child health at two years corrected age after antenatal exposure to dexamethasone or betamethasone; a randomised trial

给有早产风险的妇女服用地塞米松或倍他米松都能显著改善新生儿和儿童的健康。关于地塞米松是否比倍他米松更好，有相互矛盾的报道。这项随机试验将对此进行评估。如果地塞米松更有益，死亡和残疾儿童就会更少。这对于护理有早产风险的妇女、她们的孩子以及澳大利亚和国际上的卫生服务将非常重要。

Both dexamethasone or betamethasone, given to women at risk of preterm birth substantially improve neonatal and child health. There are conflicting reports as to whether dexamethasone is better than betamethasone? This randomised trial will assess this. If dexamethasone is more beneficial, there will be fewer deaths and fewer disabled children. This will be of great importance for the care of women at risk of preterm birth, their children and health services in Australia and internationally.